Correlation Between Solid Biosciences and AN2 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Solid Biosciences and AN2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Solid Biosciences and AN2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Solid Biosciences LLC and AN2 Therapeutics, you can compare the effects of market volatilities on Solid Biosciences and AN2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Solid Biosciences with a short position of AN2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Solid Biosciences and AN2 Therapeutics.
Diversification Opportunities for Solid Biosciences and AN2 Therapeutics
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Solid and AN2 is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Solid Biosciences LLC and AN2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AN2 Therapeutics and Solid Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Solid Biosciences LLC are associated (or correlated) with AN2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AN2 Therapeutics has no effect on the direction of Solid Biosciences i.e., Solid Biosciences and AN2 Therapeutics go up and down completely randomly.
Pair Corralation between Solid Biosciences and AN2 Therapeutics
Given the investment horizon of 90 days Solid Biosciences LLC is expected to generate 1.01 times more return on investment than AN2 Therapeutics. However, Solid Biosciences is 1.01 times more volatile than AN2 Therapeutics. It trades about 0.03 of its potential returns per unit of risk. AN2 Therapeutics is currently generating about -0.01 per unit of risk. If you would invest 630.00 in Solid Biosciences LLC on September 2, 2024 and sell it today you would lose (60.00) from holding Solid Biosciences LLC or give up 9.52% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Solid Biosciences LLC vs. AN2 Therapeutics
Performance |
| Timeline |
| Solid Biosciences LLC |
| AN2 Therapeutics |
Solid Biosciences and AN2 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Solid Biosciences and AN2 Therapeutics
The main advantage of trading using opposite Solid Biosciences and AN2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Solid Biosciences position performs unexpectedly, AN2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AN2 Therapeutics will offset losses from the drop in AN2 Therapeutics' long position.| Solid Biosciences vs. Century Therapeutics | Solid Biosciences vs. Edgewise Therapeutics | Solid Biosciences vs. C4 Therapeutics | Solid Biosciences vs. Mineralys Therapeutics, Common |
| AN2 Therapeutics vs. Tff Pharmaceuticals | AN2 Therapeutics vs. Eliem Therapeutics | AN2 Therapeutics vs. Inhibrx | AN2 Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |